WikromWongwanichKarnsakulMD
Pediatric Gastroenterology • Baltimore, MDAssociate Professor of Pediatrics, Johns Hopkins University School of Medicine
Dr. Karnsakul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 N. Wolfe Street
Rubenstein Child Health Building
Baltimore, MD 21287Phone+1 410-955-8769Fax+1 410-955-1464- Is this information wrong?
Summary
- Dr. Karnsakul is an Associate Professor of Pediatrics and a board-certified Pediatric Gastroenterologist and Hepatologist and has served as a Transplant Hepatologist of the Pediatric Liver Center at Johns Hopkins Children's Center since 2008. He trained in Pediatric Gastroenterology, Hepatology and Nutrition at Texas Children’s Hospital/ Baylor College School of Medicine. Dr. Karnsakul’s clinical interest is to improve the care and quality of life for children with chronic liver diseases and particularly those who suffer from end stage liver disease and need an evaluation for both deceased and living donor liver transplantations.
Dr. Karnsakul has been an active investigator for other NIH-funded liver-related research studies in The Pediatric Acute Liver Failure (PALF) Study and The Childhood Liver Disease Research and Education Network (ChiLDReN), and several clinical trials in children with Hepatitis C Infection. Dr. Karnsakul is the Principal Investigator on several liver disease studies for children with Cystic Fibrosis funded by NIH and Cystic Fibrosis Foundation at Johns Hopkins Children's Center. He is a member of Special Interest Group in Emerging Hepatitis E Virus in the United States at Johns Hopkins School of Medicine and has been a mentor to Johns Hopkins undergraduate, post doctorate and PhD students for the study of Hepatitis E infection in Solid Organ Transplant Recipients. In addition, he is a member of North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) since 1998 and American Association for the Study of Liver Diseases (AASLD) since 2007 and also served as Pediatric Hepatology Committee at NASPGHAN and Annual Meeting Education Committee at the AASLD.
Education & Training
Baylor College of MedicineFellowship, Pediatric Gastroenterology, 1998 - 2001
Advocate Health Care/Advocate Children’s Hospital (Oak Lawn)Residency, Pediatrics, 1995 - 1998
Mahidol University Faculty of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 2020 - 2026
MD State Medical License 2008 - 2024
WV State Medical License 2004 - 2008
TX State Medical License 2000 - 2004
IL State Medical License 1995 - 1999- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Fellow’s Clinical Research Award Society for Pediatric Research, 2001
- Drewes Scholarship Award for Clinical Externship in Pediatrics Thai-German Student Associations, 1992
Clinical Trials
- MRI to Characterize and Predict CF Liver Disease in PUSH Cohort Start of enrollment: 2017 Jan 27
- Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) Start of enrollment: 2020 Jul 08
Publications & Presentations
PubMed
- Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children.Hartley, C., Jarasvaraparn, C., Karnsakul, W.> ;Pathogens. 2024 Feb 16
- A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study.Paul Wasuwanich, Joshua M So, Brett Presnell, Wikrom Karnsakul, Robert S Egerman, Tony S Wen> ;Pathogens. 2024 Jan 3
- Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.Hansen, B., Vandriel, S., Vig, P., Garner, W., Mogul, D., Loomes, K., Piccoli, D., Rand, E., Jankowska, I., Czubkowski, P., Gliwicz-Miedzińska, D., Gonzales, E., Jacqu...> ;Hepatology. 2023 Dec 25
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Simple biomarkers correlate with liver ultrasound scan abnormalities in children with cystic fibrosisLing SC, Ye W, Leung DH, Weymann A, Karnsakul W, Freeman AJ, Magee J, Narkewicz MR for CFLD NET, AASLD, Boston, MA, 11/11/2016
- Simple biomarkers correlate with liver ultrasound scan abnormalities in children with cystic fibrosisLing SC, Ye W, Leung DH, Weymann A, Karnsakul W, Freeman AJ, Magee J, Narkewicz MR for CFLD NET, 2016 North American Cystic Fibrosis Conference, Orlando, Florida, 10/26/2016
- Frequency and Risk Factors for Variceal Hemorrhage in CF Foundation Patient Registry Participants with Cystic Fibrosis (CF) CirrhosisWen Ye, Michael R Narkewicz, Daniel H Leung, Wikrom Karnsakul, Karen F Murray, Estella M Alonso, John Magee, Sarah Jane Schwarzenberg, Alex Weymann, Jean P Molleston,..., World Congress of Pediatric Gastroenterology, Montreal, Canada, 10/2016
- Join now to see all
Lectures
- Hepatitis E virus infection in solid organ transplant: Is this an emerging disease in the United States?Department of Transplant Medicine, Georgetown University School of Medicine, Washington, DC - 2015
- Updates in Cystic Fibrosis associated Liver Disease: A story from Bedside to BenchCystic Fibrosis Foundation, Bethesda, Maryland - 2015
- Living donor liver transplantation in children: a single North American center experience over two decadesDivision of Pediatric Gastroenterology, Texas Children's Hospital - 2012
- Join now to see all
Grant Support
- Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisNIH/NIDDK and Cystic Fibrosis Foundation2009–2017
- A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV-InfectionGilead2015–2016
- A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in GileadGilead2014–2016
- A Phase 2, Open-Label, Multicenter Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV InfectionGilead2014–2016
Committees
- Pediatric Hepatology Committee, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition 2016 - Present
- Annual Meeting Education Committee, American Association for the Study of Liver Diseases 2014 - Present
Research History
- Hepatology ResearchDr. Karnsakul is an active investigator of NIH-funded Childhood Liver Disease Research and Education Network (CHilDREN) since 2008, focusing on cholestatic liver diseases,cystic fibrosis liver disease and portal hypertension with a strong interest in viral hepatitis-Hepatitis C and Hepatitis E.2008 - Present
Professional Memberships
- American Association for the Study of Liver Diseases (AASLD)Member
- North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)Member
Other Languages
- Thai, Spanish
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
Johns Hopkins Childrens CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/wikrom-karnsakul
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
